Δευτέρα 22 Φεβρουαρίου 2016

Large-Scale Prospective Pharmacogenomics Study of Oxaliplatin-Induced Neuropathy in Colon Cancer Patients enrolled in the JFMC41-1001-C2 (JOIN Trial)

Our large-scale and prospective pharmacogenomics study of Japanese patients receiving protocol treatment of adjuvant mFOLFOX6 could not verify a role for any of the 12 SNP markers reported as being significantly associated with oxaliplatin-induced peripheral sensory neuropathy.



from Cancer via ola Kala on Inoreader http://ift.tt/1oytFAD
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου